Therapeutic Drug Monitoring Market

Product Launches and Approvals are the Key Growth Strategies Adopted by Market Players in the Therapeutic Drug Monitoring Market

The major players operating in the global therapeutic drug monitoring market are F. Hoffmann-La Roche (Switzerland), Siemens Healthineers (Germany), and Abbott Laboratories (US). The TDM market is expected to reach USD 1.63 billion by 2023 from USD 1.23 billion in 2018, at a CAGR of 5.9% during the forecast period. The growth of this market is majorly driven by the rising number of organ transplant procedures and the use of TDM in traditional anticancer therapies.

F. Hoffmann-La Roche was the leading player in the TDM market in 2017. The company’s dominant position in the market is attributed to its broad product portfolio, which includes TDM assays, clinical chemistry, and immunochemistry analyzers. Under its flagship brand, Cobas, the company offers a variety of TDM instruments, reagents, and kits that are widely used by end users across the globe. The company also has a strong geographic presence, spanning North America, Europe, the Middle East and Africa, and Asia. Roche mainly focuses on product launches to maintain its leadership position in the market. For example, in the last three years, the company has launched Elecsys Sirolimus and Everolimus immunosuppressive drug assays for TDM.

To know about the assumptions considered for the study download the pdf brochure

Abbott Laboratories held the second position in the TDM market in 2017. Abbott has a strong presence in the US and seeks to further enhance its geographical presence by strengthening its business operations in emerging high-growth markets. The company’s extensive research and development activities for product development and on-going clinical trials for newly developed medicines are expected to drive the growth of its market share in the coming years. In 2017, Abbott invested 8.2% of the total revenue in research and development activities for the development of technologically advanced diagnostics products.

Some other leading players in the global TDM market are Thermo Fisher Scientific (US), Danaher (US), bioMerieux (France), Bio-Rad Laboratories (US), BÜHLMANN Laboratories (Switzerland), SEKISUI MEDICAL (Japan), and Randox Laboratories (Ireland). These companies focus on product launches, approvals, and acquisitions to maintain their strong position in the market in the coming years.

Related Reports:

Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Technology (Fluorescence Immunoassay, Radioimmunoassay, GCMS), Class of drugs (Antibiotics, Bronchodilators), End User (Hospital Lab) - Global Forecast to 2023

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
MD 4185
RI Published ON
8/22/2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Therapeutic Drug Monitoring Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved